weitere (eventuell) wirksame Medikamente/ other possibly effective drugs

Markiert sind besonders wichtige Quellen.

• METFORMIN : Diabetes-Mittel bietet guten Schutz vor Long Covid

  faz.net, hinzugefügt am 07.04.2023, wichtige Quelle

• Testing of the inhibitory effects of loratadine and desloratadine on SARS-CoV-2 spike pseudotyped virus viropexis

  sciencedirect.com, hinzugefügt am 06.03.2022, wichtige Quelle

• 10. Februar 2022 Therapeutische Medikamente gegen die Coronavirusinfektion Covid-19

  vfa.de, hinzugefügt am 17.02.2022, wichtige Quelle

• Novartis and Molecular Partners report positive topline data from Phase 2 study for ensovibep (MP0420), a DARPin antiviral therapeutic for COVID-19

  novartis.com, hinzugefügt am 11.01.2022, wichtige Quelle

• Immune Biosolutions reports that its lead immunotherapy product IBIO123 neutralizes 100% of the SARS-CoV-2 variants of concern (VOCs), including Omicron

  immunebiosolutions.com, hinzugefügt am 11.01.2022, wichtige Quelle

• Azelastine inhibits viropexis of SARS-CoV-2 spike pseudovirus by binding to SARS-CoV-2 entry receptor ACE2

  pubmed.ncbi.nlm.nih.gov, hinzugefügt am 10.01.2022, wichtige Quelle

• Therapeutische Medikamente gegen die Coronavirusinfektion Covid-19

  vfa.de, hinzugefügt am 20.12.2021, wichtige Quelle

• COVID-19 therapeutics tracker

  raps.org, hinzugefügt am 08.03.2021, wichtige Quelle

• Picolinic acid can block Covid, flu viruses: Study

  newindianexpress.com, hinzugefügt am 05.08.2023

• The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants

  nature.com, hinzugefügt am 07.04.2023

• The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression

  sciencedirect.com, hinzugefügt am 30.12.2022

• Outpatient treatment of Covid-19 with metformin, ivermectin, and fluvoxamine and the development of Long Covid over 10-month follow-up

  medrxiv.org, hinzugefügt am 30.12.2022

• Evaluation the efficacy and safety of N-acetylcysteine inhalation spray in controlling the symptoms of patients with COVID-19: An open-label randomized controlled clinical trial

  onlinelibrary.wiley.com, hinzugefügt am 20.12.2022

• Starting with PBI-0451

  pardesbio.com, hinzugefügt am 20.12.2022

• https://clearcreekbio.com/pipeline

  clearcreekbio.com, hinzugefügt am 20.12.2022

• DF-COV-01 Drug Neutralizes COVID-19 Virus and Variants

  disabled-world.com, hinzugefügt am 20.12.2022

• The off-patent drug that could protect us from future COVID-19 variants

  cam.ac.uk, hinzugefügt am 20.12.2022

• Effect of Tenofovir Disoproxil Fumarate and Emtricitabine on nasopharyngeal SARS-CoV-2 viral load burden amongst outpatients with COVID-19: A pilot, randomized, open-label phase 2 trial

  thelancet.com, hinzugefügt am 19.11.2022

• https://www.nutraingredients.com/Article/2022/11/18/b-vitamins-demonstrate-positive-action-against-covid-19

  nutraingredients.com, hinzugefügt am 19.11.2022

• Queensland researchers find immune-boosting drug could lessen COVID-19 severity if antivirals fade

  abc.net.au, hinzugefügt am 19.11.2022

• China approves first homegrown COVID antiviral

  nature.com, hinzugefügt am 18.11.2022

• China approves first homegrown COVID antiviral

  nature.com, hinzugefügt am 15.11.2022

• Promising Anti-Cancer Drug Also May Function as COVID-19 Antiviral Therapy

  hopkinsmedicine.org, hinzugefügt am 19.09.2022

• Statin Use in Hospitalized Patients with COVID-19: A Comprehensive Analysis of the New York City Public Hospital System

  amjmed.com, hinzugefügt am 24.06.2022

• Favipiravir, camostat, and ciclesonide combination therapy in patients with moderate COVID-19 pneumonia with/without oxygen therapy: An open-label, single-center phase 3 randomized clinical trial

  thelancet.com, hinzugefügt am 08.06.2022

• A phase 2 randomized, double-blinded, placebo-controlled, multicenter trial evaluating the efficacy and safety of raloxifene for patients with mild to moderate COVID-19

  thelancet.com, hinzugefügt am 27.05.2022

• NSAID use and clinical outcomes in COVID-19 patients: a 38-center retrospective cohort study

  virologyj.biomedcentral.com, hinzugefügt am 27.05.2022

• Forscher aus Ulm entwickeln Breitband-Medikament gegen Viren

  br.de, hinzugefügt am 27.05.2022

• Famotidine activates the vagus nerve inflammatory reflex to attenuate cytokine storm

  molmed.biomedcentral.com, hinzugefügt am 27.05.2022

• Clofoctol inhibits SARS-CoV-2 replication and reduces lung pathology in mice

  journals.plos.org, hinzugefügt am 27.05.2022

• Famotidine activates the vagus nerve inflammatory reflex to attenuate cytokine storm

  pubmed.ncbi.nlm.nih.gov, hinzugefügt am 13.05.2022

• Efficacy and Safety of Lithium Treatment in SARS-CoV-2 Infected Patients

  ncbi.nlm.nih.gov, hinzugefügt am 13.05.2022

• Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial

  pubmed.ncbi.nlm.nih.gov, hinzugefügt am 13.05.2022

• Multivalent 9-O-Acetylated-sialic acid glycoclusters as potent inhibitors for SARS-CoV-2 infection

  nature.com, hinzugefügt am 13.05.2022

• Combinational benefit of antihistamines and remdesivir for reducing SARS-CoV-2 replication and alleviating inflammation-induced lung injury in mice

  pubmed.ncbi.nlm.nih.gov, hinzugefügt am 10.05.2022

• An open label randomized clinical trial of Indomethacin for mild and moderate hospitalised Covid-19 patients

  nature.com, hinzugefügt am 30.04.2022

• An open label randomized clinical trial of Indomethacin for mild and moderate hospitalised Covid-19 patients

  nature.com, hinzugefügt am 28.04.2022

• An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19

  science.org, hinzugefügt am 11.04.2022

• Lithium salts as a treatment for COVID-19: Pre-clinical outcomes

  sciencedirect.com, hinzugefügt am 05.04.2022

• A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic

  nature.com, hinzugefügt am 29.03.2022

• Sulforaphane exhibits antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses in vitro and in mice

  nature.com, hinzugefügt am 27.03.2022

• A randomized double-blind placebo-controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID-19

  thelancet.com, hinzugefügt am 11.03.2022

• Oral famotidine versus placebo in non-hospitalised patients with COVID-19: a randomised, double-blind, data-intense, phase 2 clinical trial

  gut.bmj.com, hinzugefügt am 06.03.2022

• COVID-19: Können Östrogene das Sterberisiko von älteren Frauen senken?

  aerzteblatt.de, hinzugefügt am 17.02.2022

• Why scientists are racing to develop more COVID antivirals

  nature.com, hinzugefügt am 17.02.2022

• Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern

  sciencedirect.com, hinzugefügt am 17.02.2022

• Levocetirizine and montelukast in the COVID-19 treatment paradigm

  sciencedirect.com, hinzugefügt am 17.02.2022

• Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses

  science.org, hinzugefügt am 17.02.2022

• Potential Therapeutic Use of the Rosemary Diterpene Carnosic Acid for Alzheimer’s Disease, Parkinson’s Disease, and Long-COVID through NRF2 Activation to Counteract the NLRP3 Inflammasome

  mdpi.com, hinzugefügt am 17.02.2022

• Zyesami (Aviptadil) Therapeutic

  precisionvaccinations.com, hinzugefügt am 14.02.2022

• Effect of cannabidiol on apoptosis and cellular interferon and interferon-stimulated gene responses to the SARS-CoV-2 genes ORF8, ORF10 and M protein

  biorxiv.org, hinzugefügt am 24.01.2022

• Ensovibep senkt Viruslast und Hospitalisierungrate bei COVID-19-Patienten

  gelbe-liste.de, hinzugefügt am 24.01.2022

• Novartis and Molecular Partners report positive topline data from Phase 2 study for ensovibep (MP0420), a DARPin antiviral therapeutic for COVID-19

  novartis.com, hinzugefügt am 24.01.2022

• Ensovibep neutralisiert Omikron

  bio-technopark.ch, hinzugefügt am 24.01.2022

• Why scientists are racing to develop more COVID antivirals

  nature.com, hinzugefügt am 22.01.2022

• Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants

  pubmed.ncbi.nlm.nih.gov, hinzugefügt am 12.01.2022

• Effectiveness of rosuvastatin plus colchicine, emtricitabine/tenofovir and combinations thereof in hospitalized patients with COVID-19: a pragmatic, open-label randomized trial

  thelancet.com, hinzugefügt am 30.12.2021

• Sildenafil for the Treatment of Patients With COVID-19 and Perfusion Mismatch on Subtraction Computed Tomography Angiography: A Pilot, Placebo-Controlled Randomised Trial

  papers.ssrn.com, hinzugefügt am 30.12.2021

• Intranasal inhibitor blocks omicron and other variants of SARS-CoV-2

  researchsquare.com, hinzugefügt am 29.12.2021

• Mechanisms of SARS-CoV-2 neutralization by shark variable new antigen receptors elucidated through X-ray crystallography

  nature.com, hinzugefügt am 23.12.2021

• Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial

  thelancet.com, hinzugefügt am 21.12.2021

• Proteaseinhibitor Nirmatrelvir vermeidet Hospitalisierungen wegen COVID-19 in Phase-2/3-Studie

  aerzteblatt.de, hinzugefügt am 17.12.2021

• The short isoform of the host antiviral protein ZAP acts as an inhibitor of SARS-CoV-2 programmed ribosomal frameshifting

  nature.com, hinzugefügt am 13.12.2021

• Braunschweiger Helmholtz-Forscher entdecken Corona-Hemmer

  ndr.de, hinzugefügt am 13.12.2021

• Therapeutische Medikamente gegen die Coronavirusinfektion Covid-19

  vfa.de, hinzugefügt am 08.12.2021

• The therapeutic efficacy of quercetin in combination with antiviral drugs in hospitalized COVID-19 patients: A randomized controlled trial

  pubmed.ncbi.nlm.nih.gov, hinzugefügt am 07.12.2021

• Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial

  thelancet.com, hinzugefügt am 06.12.2021

• 4′-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication

  science.org, hinzugefügt am 06.12.2021

• Follow Your Nose: A Key Clue to Understanding and Treating COVID-19

  frontiersin.org, hinzugefügt am 04.12.2021

• Fluvastatin mitigates SARS-CoV-2 infection in human lung cells

  sciencedirect.com, hinzugefügt am 01.12.2021

• Characterization of the non-covalent interaction between the PF-07321332 inhibitor and the SARS-CoV-2 main protease

  sciencedirect.com, hinzugefügt am 01.12.2021

• Emergent SARS-CoV-2 variants: comparative replication dynamics and high sensitivity to thapsigargin

  tandfonline.com, hinzugefügt am 25.11.2021

• BPC 157 as Potential Treatment for COVID-19

  sciencedirect.com, hinzugefügt am 20.11.2021

• Metformin Suppresses SARS-CoV-2 in Cell Culture

  biorxiv.org, hinzugefügt am 20.11.2021

• Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial

  thelancet.com, hinzugefügt am 19.11.2021

• A new treatment for diabetic foot ulcers could also be used to eradicate the COVID-19 virus.

  newalert.mengawasi.com, hinzugefügt am 19.11.2021

• Thiol drugs decrease SARS-CoV-2 lung injury in vivo and disrupt SARS-CoV-2 spike complex binding to ACE2 in vitro

  biorxiv.org, hinzugefügt am 19.11.2021

• COVID-19: Auch Fluoxetin könnte vor schweren Verläufen schützen

  aerzteblatt.de, hinzugefügt am 19.11.2021

• Neue Therapie-Option bei schwerer Covid-19-Erkrankung

  meduniwien.ac.at, hinzugefügt am 19.11.2021

• A stem-loop RNA RIG-I agonist protects against acute and chronic SARS-CoV-2 infection in mice

  rupress.org, hinzugefügt am 15.11.2021

• Chitinase 3-like-1 is a therapeutic target that mediates the effects of aging in COVID-19

  insight.jci.org, hinzugefügt am 09.11.2021

• Statins use and COVID-19 outcomes in hospitalized patients

  journals.plos.org, hinzugefügt am 04.11.2021

• An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19

  science.org, hinzugefügt am 04.11.2021

• Camel nanobodies broadly neutralize SARS-CoV-2 variants

  biorxiv.org, hinzugefügt am 01.11.2021

• U of T researchers create mirror-image peptides that can neutralize SARS-CoV-2

  utoronto.ca, hinzugefügt am 29.10.2021

• Is butyrate a natural alternative to dexamethasone in the management of CoVID-19?

  ncbi.nlm.nih.gov, hinzugefügt am 25.10.2021

• A prenylated dsRNA sensor protects against severe COVID-19

  science.org, hinzugefügt am 29.09.2021

• 5-Hydroxymethyltubercidin Exhibits Potent Antiviral Activity against Flaviviruses and Coronaviruses, including SARS-CoV-2

  cell.com, hinzugefügt am 20.09.2021

• Nature-Studie zur Seneszenz eröffnet neuen Therapieansatz

  charite.de, hinzugefügt am 15.09.2021

• A randomized trial of icosapent ethyl in ambulatory patients with COVID-19

  sciencedirect.com, hinzugefügt am 15.09.2021

• Fostamatinib for the treatment of hospitalized adults with COVID-19 A randomized trial

  academic.oup.com, hinzugefügt am 15.09.2021

• A Randomized Trial of Icosapent Ethyl in Ambulatory Patients with COVID-19

  sciencedirect.com, hinzugefügt am 28.08.2021

• Effect of Early Treatment with Fluvoxamine on Risk of Emergency Care and Hospitalization Among Patients with COVID-19: The TOGETHER Randomized Platform Clinical Trial

  medrxiv.org, hinzugefügt am 26.08.2021

• Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis

  thelancet.com, hinzugefügt am 26.08.2021

• Association of Antineoplastic Therapy With Decreased SARS-CoV-2 Infection Rates in Patients With Cancer

  jamanetwork.com, hinzugefügt am 26.08.2021

• Long-Covid: Erlanger Mediziner melden Erfolge mit Herzmedikament

  br.de, hinzugefügt am 26.08.2021

• A licensed drug normally used to treat abnormal levels of fatty substances in the blood could reduce infection caused by the SARS-CoV-2 virus by up to 70 per cent, reveals a study in the laboratory by an international collaboration of researchers.

  birmingham.ac.uk, hinzugefügt am 24.08.2021

• Antidepressant fluvoxamine can save COVID-19 patients, McMaster-led research shows

  brighterworld.mcmaster.ca, hinzugefügt am 24.08.2021

• Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.

  thelancet.com, hinzugefügt am 24.08.2021

• Therapeutic Solutions International Prepares to Apply for Emergency Use Authorization (EUA) for its FDA Phase III COVID-19 Stem Cell Therapy JadiCell™

  therapeuticsolutionsint.com, hinzugefügt am 24.08.2021

• Krebsmedikament reduziert in kleiner Studie Mortalität bei COVID-19-bedingtem Lungenversagen

  aerzteblatt.de, hinzugefügt am 14.08.2021

• Famotidine inhibits toll-like receptor 3-mediated inflammatory signaling in SARS-CoV-2 infection

  pubmed.ncbi.nlm.nih.gov, hinzugefügt am 03.08.2021

• Interferon-inducer antivirals: Potential candidates to combat COVID-19

  ncbi.nlm.nih.gov, hinzugefügt am 03.08.2021

• Proxalutamide Improves Inflammatory, Immunologic, and Thrombogenic Markers in Mild-to-Moderate COVID-19 Males and Females: an Exploratory Analysis of a Randomized, Double-Blinded, Placebo-Controlled Trial Early Antiandrogen Therapy (EAT) with Proxalutamide

  medrxiv.org, hinzugefügt am 27.07.2021

• Proxalutamide Improves Inflammatory, Immunologic, and Thrombogenic Markers in Mild-to-Moderate COVID-19 Males and Females: an Exploratory Analysis of a Randomized, Double-Blinded, Placebo-Controlled Trial Early Antiandrogen Therapy (EAT) with Proxalutamide

  medrxiv.org, hinzugefügt am 27.07.2021

• Programmable icosahedral shell system for virus trapping

  nature.com, hinzugefügt am 19.07.2021

• Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial

  thelancet.com, hinzugefügt am 17.07.2021

• Kintor Pharmaceutical Receives Emergency Use Authorization for Proxalutamide for the Treatment of COVID-19 in Paraguay

  en.kintor.com.cn, hinzugefügt am 17.07.2021

• Gen-Schere kann Coronavirus stoppen

  n-tv.de, hinzugefügt am 14.07.2021

• WHO recommends Roche, Sanofi drugs for COVID-19 to cut death risk

  ctvnews.ca, hinzugefügt am 09.07.2021

• Early COVID-19 Therapy with azithromycin plus nitazoxanide, ivermectin or hydroxychloroquine in Outpatient Settings Significantly Improved COVID-19 outcomes compared to Known outcomes in untreated patients

  sciencedirect.com, hinzugefügt am 09.07.2021

• WHO empfiehlt IL-6-Antagonisten bei COVID-19

  aerzteblatt.de, hinzugefügt am 09.07.2021

• Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19

  jamanetwork.com, hinzugefügt am 09.07.2021

• Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label Study

  pubmed.ncbi.nlm.nih.gov, hinzugefügt am 07.07.2021

• NRx Pharmaceuticals Announces Positive Data Results from ZYESAMI™ (Aviptadil) Expanded Access Protocol

  ir.nrxpharma.com, hinzugefügt am 23.06.2021

• Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease

  cell.com, hinzugefügt am 23.06.2021

• Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial

  pubmed.ncbi.nlm.nih.gov, hinzugefügt am 23.06.2021

• Efficacy of Proxalutamide in Hospitalized COVID-19 Patients: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design Clinical Trial

  medrxiv.org, hinzugefügt am 23.06.2021

• Efficacy of Proxalutamide in Hospitalized COVID-19 Patients: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design Clinical Trial

  medrxiv.org, hinzugefügt am 23.06.2021

• A diamidobenzimidazole STING agonist protects against SARS-CoV-2 infection

  immunology.sciencemag.org, hinzugefügt am 23.06.2021

• Studie: Krebsmedikament Imatinib könnte Mortalität von COVID-19-Patienten senken

  aerzteblatt.de, hinzugefügt am 23.06.2021

• Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial

  thelancet.com, hinzugefügt am 23.06.2021

• Neuer Therapieansatz? Bandwurmmittel senkt Sars-CoV-2-Produktion in Zellen um über 99 Prozent

  rnd.de, hinzugefügt am 22.06.2021

• NRx Pharmaceuticals Announces Positive Data Results from ZYESAMI™ (Aviptadil) Expanded Access Protocol

  ir.nrxpharma.com, hinzugefügt am 20.06.2021

• ETH-Spin-off plant neues Anti-Corona-Medikament

  20min.ch, hinzugefügt am 20.06.2021

• Early multidrug treatment of SARS-CoV-2 infection (COVID-19) and reduced mortality among nursing home (or outpatient/ambulatory) residents

  sciencedirect.com, hinzugefügt am 20.06.2021

• Pfizer Medicine Reduces The Risk of Death from Covid-19 by 37%, Reveals Study Carried Out in Brazil

  www1.folha.uol.com.br, hinzugefügt am 20.06.2021

• Telmisartan for treatment of Covid-19 patients: An open multicenter randomized clinical trial

  thelancet.com, hinzugefügt am 20.06.2021

• COVID-19: JAK-Inhibitor Tofacitinib verbessert Prognose von hospitalisierten Patienten

  aerzteblatt.de, hinzugefügt am 20.06.2021

• Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia

  nejm.org, hinzugefügt am 20.06.2021

• Senolytics reduce coronavirus-related mortality in old mice

  science.sciencemag.org, hinzugefügt am 20.06.2021

• SARS-CoV-2: Senolytikum erhöht Überlebenschancen in präklinischer Studie

  aerzteblatt.de, hinzugefügt am 09.06.2021

• Comment on: “Prior Treatment with Statins is Associated with Improved Outcomes of Patients with COVID-19: Data from the SEMI-COVID-19 Registry”

  link.springer.com, hinzugefügt am 09.06.2021

• Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants

  nature.com, hinzugefügt am 09.06.2021

• Could Statins Do More Than Lower Cholesterol in Patients With COVID-19?

  jamanetwork.com, hinzugefügt am 09.06.2021

• “Nanotraps” Designed to Capture and Clear SARS-CoV-2

  jamanetwork.com, hinzugefügt am 09.06.2021

• In-hospital use of statins is associated with a reduced risk of mortality in coronavirus-2019 (COVID-19): systematic review and meta-analysis

  link.springer.com, hinzugefügt am 09.06.2021

• NRx Pharmaceuticals Announces Positive Results for ZYESAMI™ (Aviptadil-acetate) and Submits Emergency Use Authorization Application to US Food and Drug Administration to Treat Critical COVID-19 in Patients Suffering from Respiratory Failure

  ir.nrxpharma.com, hinzugefügt am 06.06.2021

• NIH researchers identify potential new antiviral drug for COVID-19

  nih.gov, hinzugefügt am 06.06.2021

• SARS-CoV-2-Infektion: Lokale Behandlung mit physikalischem Plasma

  heilpraxisnet.de, hinzugefügt am 06.06.2021

• Early Anakinra Treatment for COVID-19 Guided by Urokinase Plasminogen Receptor

  medrxiv.org, hinzugefügt am 28.05.2021

• A diamidobenzimidazole STING agonist protects against SARS-CoV-2 infection

  immunology.sciencemag.org, hinzugefügt am 25.05.2021

• Pharmacological activation of STING blocks SARS-CoV-2 infection

  immunology.sciencemag.org, hinzugefügt am 25.05.2021

• Synairgen announces results of in vitro studies showing antiviral activity of interferon beta ag

  synairgen.com, hinzugefügt am 25.05.2021

• Queensland scientists develop peptide-based drugs that could reduce severity of COVID-19

  abc.net.au, hinzugefügt am 25.05.2021

• 406-11 - Effects Of Dapagliflozin On Prevention Of Major Clinical Events And Recovery In Patients With Respiratory Failure Due To COVID-19 - Main Results From The DARE-19 Randomized Trial

  abstractsonline.com, hinzugefügt am 22.05.2021

• Early use of anakinra reduces risk of mortality for patients with COVID-19 pneumonia, reduces ICU admission and increases likelihood of full recovery

  news.cision.com, hinzugefügt am 22.05.2021

• Virucidal and antiviral activity of astodrimer sodium against SARS-CoV-2 in vitro

  sciencedirect.com, hinzugefügt am 22.05.2021

• World-first COVID-19 antiviral therapy developed in Brisbane and US targets virus in the body

  abc.net.au, hinzugefügt am 20.05.2021

• Researchers develop direct-acting antiviral therapy to treat COVID-19

  news.griffith.edu.au, hinzugefügt am 20.05.2021

• A Randomized Placebo-Controlled Trial of Sarilumab in Hospitalized Patients with Covid-19

  medrxiv.org, hinzugefügt am 15.05.2021

• A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19

  cell.com, hinzugefügt am 15.05.2021

• Engineering mesenchymal stromal cells with neutralizing and anti-inflammatory capability against SARS-CoV-2 infection

  cell.com, hinzugefügt am 15.05.2021

• Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study

  bmj.com, hinzugefügt am 13.05.2021

• WHO startet Prüfung von drei potenziellen Covid-19-Medikamenten

  spiegel.de, hinzugefügt am 12.05.2021

• International COVID-19 trial to restart with focus on immune responses

  nature.com, hinzugefügt am 12.05.2021

• Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study

  thelancet.com, hinzugefügt am 10.05.2021

• Europäische Arzneimittelagentur untersucht neue COVID-19-Therapie

  aerzteblatt.de, hinzugefügt am 08.05.2021

• The Use of Amantadine in the Prevention of Progression and Treatment of COVID-19 Symptoms (COV-PREVENT)

  clinicaltrials.gov, hinzugefügt am 07.05.2021

• A machine learning platform to estimate anti-SARS-CoV-2 activities

  nature.com, hinzugefügt am 07.05.2021

• Human Organ Chips Shift Amodiaquine from Old Antimalarial to Promising COVID-19 Treatment

  genengnews.com, hinzugefügt am 05.05.2021

• A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics

  nature.com, hinzugefügt am 04.05.2021

• Fluoxetine as an anti-inflammatory therapy in SARS-CoV-2 infection

  sciencedirect.com, hinzugefügt am 03.05.2021

• Pfizer CEO Says Antiviral Pill To Treat Covid Could Be Ready By The End Of The Year

  forbes.com, hinzugefügt am 30.04.2021

• A monoclonal antibody against staphylococcal enterotoxin B superantigen inhibits SARS-CoV-2 entry in vitro

  cell.com, hinzugefügt am 30.04.2021

• Hepatitis C Virus Drugs That Inhibit the SARS-CoV-2 Papain-Like Protease Synergize with Remdesivir to Suppress Viral Replication in Cell Culture

  cell.com, hinzugefügt am 30.04.2021

• Wie vielversprechend ist die Anti-Corona-Pille von Pfizer?

  t-online.de, hinzugefügt am 30.04.2021

• Network medicine framework for identifying drug-repurposing opportunities for COVID-19

  pnas.org, hinzugefügt am 30.04.2021

• Nanobodies inhibit SARS-CoV-2 infection, including emergent variants

  phys.org, hinzugefügt am 29.04.2021

• The Efficacy of Famotidine in improvement of outcomes in Hospitalized COVID-19 Patients: A phase III randomised clinical trial

  researchsquare.com, hinzugefügt am 29.04.2021

• Role of Statins in Coronavirus-Related Disease (COVID-19): A Retrospective Cohort Study in Northern Italy

  link.springer.com, hinzugefügt am 29.04.2021

• Anti-inflammatory potential of Quercetin in COVID-19 treatment

  journal-inflammation.biomedcentral.com, hinzugefügt am 25.04.2021

• Inhibition of acid sphingomyelinase by ambroxol prevents SARS-CoV-2 entry into epithelial cells

  sciencedirect.com, hinzugefügt am 24.04.2021

• Early treatment with nitazoxanide prevents worsening of mild and moderate COVID-19 and subsequent hospitalization

  medrxiv.org, hinzugefügt am 21.04.2021

• Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19

  frontiersin.org, hinzugefügt am 21.04.2021

• Nanotraps for the containment and clearance of SARS-CoV-2

  cell.com, hinzugefügt am 21.04.2021

• Positive Topline Data Shows Fostamatinib Meets Primary Endpoint of Safety in Phase 2 Clinical Trial in Hospitalized Patients with COVID-19

  rigel.com, hinzugefügt am 19.04.2021

• Evaluation of Thiamine as Adjunctive Therapy in COVID-19 Critically Ill Patients: A Multicenter Propensity Score Matched Study

  researchsquare.com, hinzugefügt am 15.04.2021

• Case Report: Famotidine for Neuropsychiatric Symptoms in COVID-19

  frontiersin.org, hinzugefügt am 15.04.2021

• Amantadine in the prevention of clinical symptoms caused by SARS-CoV-2

  link.springer.com, hinzugefügt am 14.04.2021

• Amantadine Inhibits SARS-CoV-2 In Vitro

  mdpi.com, hinzugefügt am 14.04.2021

• Role of Aviptadil in COVID-19

  lastfuturist.com, hinzugefügt am 13.04.2021

• MedUni Wien entwickelt Medikament gegen schwere Covid-Verläufe

  vienna.at, hinzugefügt am 12.04.2021

• Two Currently Available Medications – an Antifungal and an Antidepressant – May Help Protect Against COVID-19

  scitechdaily.com, hinzugefügt am 09.04.2021

• Drugs that inhibit TMEM16 proteins block SARS-CoV-2 Spike-induced syncytia

  nature.com, hinzugefügt am 07.04.2021

• Ciclosporin und Pelitinib könnten gegen SARS-CoV-2 wirksam sein

  aerzteblatt.de, hinzugefügt am 07.04.2021

• Grifols announces topline data from NIAID Phase 3 ITAC trial (INSIGHT-013) evaluating hyperimmune globulins as a treatment for hospitalized patients with COVID-19

  intranet.grifols.com, hinzugefügt am 06.04.2021

• Oraler Proteasehemmer gegen Corona geht in klinische Prüfung

  pharmazeutische-zeitung.de, hinzugefügt am 05.04.2021

• Ascorbic Acid as an Adjunctive Therapy in Critically Ill Patients with COVID-19: A Multicenter Propensity Score Matched Study

  researchsquare.com, hinzugefügt am 04.04.2021

• Medicinal Plants, Phytochemicals, and Herbs to Combat Viral Pathogens Including SARS-CoV-2

  mdpi.com, hinzugefügt am 04.04.2021

• X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease

  science.sciencemag.org, hinzugefügt am 03.04.2021

• Real-world Evidence for Improved Outcomes with Histamine Antagonists and Aspirin in 22,560 COVID-19 Patients

  researchsquare.com, hinzugefügt am 01.04.2021

• TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation.

  cell.com, hinzugefügt am 30.03.2021

• NeuroRx Announces ZYESAMI™ (aviptadil, RLF-100) Met the Primary Endpoint of Its Phase 2b/3 Clinical Trial and Also Demonstrated a Meaningful Benefit in Survival from Critical COVID-19

  prnewswire.com, hinzugefügt am 29.03.2021

• Identification of antiviral antihistamines for COVID-19 repurposing

  sciencedirect.com, hinzugefügt am 28.03.2021

• Potential anti-COVID-19 agents, Cepharanthine and Nelfinavir, and their usage for combination treatment

  cell.com, hinzugefügt am 28.03.2021

• PDF [8 MB] Figures Save Share Reprints Request Potential anti-COVID-19 agents, Cepharanthine and Nelfinavir, and their usage for combination treatment

  cell.com, hinzugefügt am 27.03.2021

• Opaganib Krebsmedikament gegen Covid-19 in Erprobung

  pharmazeutische-zeitung.de, hinzugefügt am 26.03.2021

• Opaganib in Italien im Härtefalleinsatz

  deutsche-apotheker-zeitung.de, hinzugefügt am 26.03.2021

• Aspirin könnte Corona-Infektionsrisiko laut Studie „signifikant“ reduzieren

  fr.de, hinzugefügt am 26.03.2021

• Rapid Clinical Recovery from Critical COVID-19 Pneumonia with Vasoactive Intestinal Peptide Treatment

  sciencedirect.com, hinzugefügt am 25.03.2021

• Does the secret to an effective COVID-19 treatment lie in a protease inhibitor?

  pfizer.com, hinzugefügt am 24.03.2021

• Neutrons reveal unpredicted binding between SARS-CoV-2, hepatitis C antiviral drug

  ornl.gov, hinzugefügt am 24.03.2021

• Antidepressant and antipsychotic drugs reduce viral infection by SARS-CoV-2 and fluoxetine show antiviral activity against the novel variants in vitro

  biorxiv.org, hinzugefügt am 24.03.2021

• Therapeutic effects of adenosine in high flow 21% oxygen aereosol in patients with Covid19-pneumonia

  journals.plos.org, hinzugefügt am 22.03.2021

• In vitro characterization of engineered red blood cells as viral traps against HIV-1 and SARS-CoV-2

  cell.com, hinzugefügt am 19.03.2021

• Clofazimine broadly inhibits coronaviruses including SARS-CoV-2

  nature.com, hinzugefügt am 18.03.2021

• BET Inhibition Blocks Inflammation-Induced Cardiac Dysfunction and SARS-CoV-2 Infection

  cell.com, hinzugefügt am 17.03.2021

• Discovery of Clioquinol and Analogues as Novel Inhibitors of Severe Acute Respiratory Syndrome Coronavirus 2 Infection, ACE2 and ACE2 - Spike Protein Interaction In Vitro

  cell.com, hinzugefügt am 14.03.2021

• Androgen Receptors for COVID-19

  blogs.sciencemag.org, hinzugefügt am 13.03.2021

• Kintor Pharmaceutical Announces Results from Investigator-Initiated Brazil Trial Demonstrating 92% Reduction in Mortality in Hospitalized COVID-19 Patients

  en.kintor.com.cn, hinzugefügt am 13.03.2021

• Kintor Pharmaceutical Announces Results from Investigator-Initiated Brazil Trial Demonstrating 92% Reduction in Mortality in Hospitalized COVID-19 Patients

  biospace.com, hinzugefügt am 11.03.2021

• ANN KOMMT AT-527?: Das wissen wir bereits über die Anti-Corona-Pille von Roche

  20min.ch, hinzugefügt am 10.03.2021

• Seeking to combat COVID-19 with an oral RNA viral polymerase inhibitor.

  ateapharma.com, hinzugefügt am 10.03.2021

• Antihistamines and azithromycin as a treatment for COVID-19 on primary health care – A retrospective observational study in elderly patients

  sciencedirect.com, hinzugefügt am 10.03.2021

• Ridgeback Biotherapeutics and Merck Announce Preliminary Findings from a Phase 2a Trial of Investigational COVID-19 Therapeutic Molnupiravir

  merck.com, hinzugefügt am 07.03.2021

• Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

  thelancet.com, hinzugefügt am 06.03.2021

• Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity

  sciencedirect.com, hinzugefügt am 04.03.2021

• Antioxidants and pentoxifylline as coadjuvant measures to standard therapy to improve prognosis of patients with pneumonia by COVID-19

  sciencedirect.com, hinzugefügt am 04.03.2021

• The study of antiviral drugs targeting SARS-CoV-2 nucleocapsid and spike proteins through large-scale compound repurposing

  cell.com, hinzugefügt am 04.03.2021

• Targeting androgen regulation of TMPRSS2 and ACE2 as a therapeutic strategy to combat COVID-19

  sciencedirect.com, hinzugefügt am 03.03.2021

• Studie identifiziert mögliche Hemmstoffe von SARS-CoV-2

  aerzteblatt.de, hinzugefügt am 02.03.2021

• Simultaneous Inhibition of SARS-CoV-2 Entry Pathways by Cyclosporine

  pubs.acs.org, hinzugefügt am 02.03.2021

• Innovation Pharma Provides Study Details for Ongoing Phase 2 Clinical Trial of Brilacidin in Hospitalized COVID-19 Patients

  ipharminc.com, hinzugefügt am 28.02.2021

• A Scoping Insight on Potential Prophylactics, Vaccines and Therapeutic Weaponry for the Ongoing Novel Coronavirus (COVID-19) Pandemic- A Comprehensive Review

  frontiersin.org, hinzugefügt am 28.02.2021

• Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results

  nejm.org, hinzugefügt am 26.02.2021

• Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 with Planned Completion and Emergency Use Authorization Request

  globenewswire.com, hinzugefügt am 26.02.2021

• Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study

  nature.com, hinzugefügt am 26.02.2021

• INDEPENDENT DATA MONITORING COMMITTEE FINDS CLEAR EFFICACY FOR REGEN-COV™ (CASIRIVIMAB WITH IMDEVIMAB) IN PHASE 3 COVID-19 OUTPATIENT OUTCOMES TRIAL

  investor.regeneron.com, hinzugefügt am 26.02.2021

• Israeli researchers say spirulina algae could reduce COVID mortality rate

  jpost.com, hinzugefügt am 26.02.2021

• Could fluvoxamine keep COVID19 patients out of hospitals and intensive care units?

  neuron.mefst.hr, hinzugefügt am 26.02.2021

• SARS-CoV-2 dependence on host pathways

  science.sciencemag.org, hinzugefügt am 26.02.2021

• Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial

  cureus.com, hinzugefügt am 24.02.2021

• NeuroRx Announces that ZYESAMI™ (Aviptadil) has Successfully Demonstrated 10-Day Accelerated Recovery from Respiratory Failure in Critically Ill Patients with Covid-19 Treated with High Flow Nasal Oxygen at 28-Day Interim Endpoint

  prnewswire.com, hinzugefügt am 24.02.2021

• Sulodexide in the Treatment of Early Stages of COVID-19

  sciencedirect.com, hinzugefügt am 20.02.2021

• Bepridil is potent against SARS-CoV-2 in vitro

  pnas.org, hinzugefügt am 20.02.2021

• SARS-CoV-2 Mpro inhibitors with antiviral activity in a transgenic mouse model

  science.sciencemag.org, hinzugefügt am 19.02.2021

• Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections

  nature.com, hinzugefügt am 18.02.2021

• SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801

  pubmed.ncbi.nlm.nih.gov, hinzugefügt am 18.02.2021

• ACTIV Update: Making Major Strides in COVID-19 Therapeutic Development

  directorsblog.nih.gov, hinzugefügt am 17.02.2021

• Groundbreaking COVID-19 treatments to be fast-tracked through clinical trials

  gov.uk, hinzugefügt am 16.02.2021

• Can glycine mitigate COVID-19 associated tissue damage and cytokine storm ?

  ncbi.nlm.nih.gov, hinzugefügt am 13.02.2021

• Four potential COVID-19 therapeutics enter Phase 2/3 testing in NIH ACTIV-2 trial

  nih.gov, hinzugefügt am 13.02.2021

• Asthmaspray mit Budesonid verhindert schwere Verläufe

  aerzteblatt.de, hinzugefügt am 12.02.2021

• Proxalutamide (GT0918) Reduces the Rate of Hospitalization and Death in COVID-19 Male Patients: A Randomized Double-Blinded Placebo-Controlled Trial.

  researchsquare.com, hinzugefügt am 12.02.2021

• NeuroRx reports Initial Phase 2b/3 Study Results Demonstrating Significant Benefit of ZYESAMI™ (aviptadil) in Reducing Hospital Stay among Patients with Respiratory Failure due to Critical COVID-19

  neurorxpharma.com, hinzugefügt am 10.02.2021

• In vivo structural characterization of the SARS-CoV-2 RNA genome identifies host proteins vulnerable to repurposed drugs

  cell.com, hinzugefügt am 10.02.2021

• SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801

  nature.com, hinzugefügt am 10.02.2021

• Common asthma treatment reduces need for hospitalisation in COVID-19 patients, study suggests

  oxfordbrc.nihr.ac.uk, hinzugefügt am 09.02.2021

• Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial

  thelancet.com, hinzugefügt am 07.02.2021

• New Israeli drug cured 29 of 30 moderate/serious COVID cases in days — hospital

  timesofisrael.com, hinzugefügt am 06.02.2021

• Thapsigargin Is a Broad-Spectrum Inhibitor of Major Human Respiratory Viruses: Coronavirus, Respiratory Syncytial Virus and Influenza A Virus

  mdpi.com, hinzugefügt am 04.02.2021

• Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

  thelancet.com, hinzugefügt am 04.02.2021

• Prospective cohort of fluvoxamine for early treatment of COVID-19

  academic.oup.com, hinzugefügt am 02.02.2021

• 17β‐estradiol reduces SARS‐CoV‐2 infection in vitro

  physoc.onlinelibrary.wiley.com, hinzugefügt am 31.01.2021

• plitidepsin (Aplidin), a drug approved by the Australian Regulatory Agency for the treatment of multiple myeloma, has potent antiviral activity against SARS-CoV-2

  ucsf.edu, hinzugefügt am 28.01.2021

• Coronavirus replication–transcription complex: Vital and selective NMPylation of a conserved site in nsp9 by the NiRAN-RdRp subunit

  pnas.org, hinzugefügt am 26.01.2021

• Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A

  science.sciencemag.org, hinzugefügt am 26.01.2021

• Host-directed therapies against early-lineage SARS-CoV-2 retain efficacy against B.1.1.7 variant

  biorxiv.org, hinzugefügt am 26.01.2021

• Woran die Pharmabranche forscht Schwierige Suche nach Covid-Medikamenten

  tagesschau.de, hinzugefügt am 25.01.2021

• Fecal microbiota transplantation for COVID-19; a potential emerging treatment strategy

  sciencedirect.com, hinzugefügt am 24.01.2021

• N-Acetylcysteine to Combat COVID-19: An Evidence Review

  ncbi.nlm.nih.gov, hinzugefügt am 24.01.2021

• Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents

  nature.com, hinzugefügt am 22.01.2021

• α1-Antitrypsin deficiency and the risk of COVID-19: an urgent call to action

  thelancet.com, hinzugefügt am 22.01.2021

• GABA administration prevents severe illness and death following coronavirus infection in mice

  ncbi.nlm.nih.gov, hinzugefügt am 20.01.2021

• COVID-19—The Potential Beneficial Therapeutic Effects of Spironolactone during SARS-CoV-2 Infection

  mdpi.com, hinzugefügt am 18.01.2021

• Artemisia annua L. extracts prevent in vitro replication of SARS-CoV-2

  biorxiv.org, hinzugefügt am 13.01.2021

• Enisamium is an inhibitor of the SARS-CoV-2 RNA polymerase and shows improvement of recovery in COVID-19 patients in an interim analysis of a clinical trial

  medrxiv.org, hinzugefügt am 13.01.2021

• The hyperlipidaemic drug fenofibrate significantly reduces infection by SARS-CoV-2 in cell culture models

  biorxiv.org, hinzugefügt am 12.01.2021

• Antiviral drugs in hospitalized patients with COVID-19 - the DisCoVeRy trial

  medrxiv.org, hinzugefügt am 11.01.2021

• Repurposing of CNS drugs to treat COVID-19 infection: targeting the sigma-1 receptor

  link.springer.com, hinzugefügt am 10.01.2021

• Impact of colchicine on mortality in patients with COVID-19. A meta-analysis.

  sciencedirect.com, hinzugefügt am 08.01.2021

• Quercetin: Antiviral Significance and Possible COVID-19 Integrative Considerations

  journals.sagepub.com, hinzugefügt am 08.01.2021

• Existing antihistamine drugs show effectiveness against COVID-19 virus in cell testing

  m.ufhealth.org, hinzugefügt am 07.01.2021

• FBA reveals guanylate kinase as a potential target for antiviral therapies against SARS-CoV-2

  academic.oup.com, hinzugefügt am 06.01.2021

• Guanylatkinase (GK1) SARS-CoV-2: Bioinformatiker entdecken eine neue Schwachstelle des Virus

  dzif.de, hinzugefügt am 06.01.2021

• Umbilical stem cells show promise against severe COVID-19

  upi.com, hinzugefügt am 06.01.2021

• CoViTris2020 and ChloViD2020: a striking new hope in COVID-19 therapy

  link.springer.com, hinzugefügt am 06.01.2021

• Umbilical cord mesenchymal stem cells for COVID‐19 acute respiratory distress syndrome: A double‐blind, phase 1/2a, randomized controlled trial

  stemcellsjournals.onlinelibrary.wiley.com, hinzugefügt am 06.01.2021

• Amantadin has potential for the treatment of COVID-19 because it targets known and novel ion channels encoded by SARS-CoV-2

  researchsquare.com, hinzugefügt am 05.01.2021

• SARS-CoV-2: ACE-Hemmer könnten Risiko auf schweren Krankheitsverlauf senken

  aerzteblatt.de, hinzugefügt am 05.01.2021

• Mushroom-derived bioactive compounds potentially serve as the inhibitors of SARS-CoV-2 main protease: an in silico approach

  sciencedirect.com, hinzugefügt am 04.01.2021

• Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19

  jamanetwork.com, hinzugefügt am 03.01.2021

• Pyrrolo[2,3-b]quinoxalines in attenuating cytokine storm in COVID-19: their sonochemical synthesis and in silico / in vitro assessment

  sciencedirect.com, hinzugefügt am 03.01.2021

• Large population study identifies drugs associated with reduced COVID-19 severity

  medrxiv.org, hinzugefügt am 01.01.2021

• Higher Survival Rate Associated with Thymosin Alpha 1 use in Critical COVID-19: A Retrospective Multicenter Cohort Study

  researchsquare.com, hinzugefügt am 30.12.2020

• SARS-CoV-2 infection: can ferroptosis be a potential treatment target for multiple organ involvement?

  pubmed.ncbi.nlm.nih.gov, hinzugefügt am 30.12.2020

• Comparing ICU Admission Rates of Mild/Moderate COVID-19 Patients Treated with Hydroxychloroquine, Favipiravir, and Hydroxychloroquine plus Favipiravir

  sciencedirect.com, hinzugefügt am 30.12.2020

• Induction of alarmin S100A8/A9 mediates activation of aberrant neutrophils in the pathogenesis of COVID-19

  cell.com, hinzugefügt am 29.12.2020

• Bosnian company produces drug that accelerates COVID-19 recovery process

  ba.n1info.com, hinzugefügt am 26.12.2020

• Human SARS-CoV-2 neutralizing antibody COR-101 demonstrates high efficacy in a COVID-19 animal model and is ready to be used in clinical studies to treat COVID-19 patients

  corat-therapeutics.com, hinzugefügt am 22.12.2020

• Can Activation of NRF2 Be a Strategy against COVID-19?

  ncbi.nlm.nih.gov, hinzugefügt am 19.12.2020

• Synairgen plc SNG001 given Fast Track designation and IND cleared by the US FDA

  globenewswire.com, hinzugefügt am 18.12.2020

• Lycorine, a non-nucleoside RNA dependent RNA polymerase inhibitor, as potential treatment for emerging coronavirus infections

  sciencedirect.com, hinzugefügt am 18.12.2020

• Foistar(Camostat mesylate) associated with the significant decrease in CRP levels compared to Kaletra(Lopinavir/Ritonavir) treatment in Korean mild COVID-19 pneumonic patients.

  medrxiv.org, hinzugefügt am 17.12.2020

• Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion

  pnas.org, hinzugefügt am 16.12.2020

• Aprotinin Inhibits SARS-CoV-2 Replication

  mdpi.com, hinzugefügt am 16.12.2020

• Thalidomide Combined with Short-term Low-Dose Glucocorticoid Therapy for the Treatment of Severe COVID-19: A Case-Series Study

  sciencedirect.com, hinzugefügt am 15.12.2020

• Hepatitis C Virus Drugs Simeprevir and Grazoprevir Synergize with Remdesivir to Suppress SARS-CoV-2 Replication in Cell Culture

  biorxiv.org, hinzugefügt am 15.12.2020

• A retrospective comparison of drugs against COVID-19

  sciencedirect.com, hinzugefügt am 15.12.2020

• RECOVERY trial finds no benefit from azithromycin in patients hospitalised with COVID-19

  recoverytrial.net, hinzugefügt am 14.12.2020

• Results of Open-Label non-Randomized Comparative Clinical Trial: “BromhexIne and Spironolactone for CoronаvirUs Infection requiring hospiTalization (BISCUIT)

  lib.ossn.ru, hinzugefügt am 14.12.2020

• Therapeutically administered ribonucleoside analogue MK-4482/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets

  nature.com, hinzugefügt am 13.12.2020

• Rationale for COVID-19 Treatment by Nebulized Interferon-β-1b–Literature Review and Personal Preliminary Experience

  frontiersin.org, hinzugefügt am 13.12.2020

• Sulodexide in the treatment of patients with early stages of COVID-19: a randomised controlled trial

  medrxiv.org, hinzugefügt am 09.12.2020

• Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019

  journal.chestnet.org, hinzugefügt am 09.12.2020

• Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis

  sciencedirect.com, hinzugefügt am 09.12.2020

• Molnupiravir (4482/EIDD-2801) Therapeutically administered ribonucleoside analogue MK-4482/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets

  nature.com, hinzugefügt am 09.12.2020

• COVID-19: Metformin könnte Sterberisiko bei Frauen mit Typ-2-Diabetes senken

  aerzteblatt.de, hinzugefügt am 09.12.2020

• The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with mild COVID-19: a pilot, double-blind, placebo-controlled, randomized clinical trial

  researchsquare.com, hinzugefügt am 08.12.2020

• Cyclosporine A plus low-dose steroid treatment in COVID-19 improves clinical outcomes in patients with moderate to severe disease. A pilot study

  pubmed.ncbi.nlm.nih.gov, hinzugefügt am 07.12.2020

• Clinically Approved Antiviral Drug in an Orally Administrable Nanoparticle for COVID-19

  pubs.acs.org, hinzugefügt am 06.12.2020

• Efficacy and Safety of Topical Ivermectin + IotaCarrageenan in the Prophylaxis against COVID-19 in Health Personnel

  medicalpressopenaccess.com, hinzugefügt am 06.12.2020

• Malleability of the SARS-CoV-2 3CL Mpro Active-Site Cavity Facilitates Binding of Clinical Antivirals

  cell.com, hinzugefügt am 06.12.2020

• Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis

  thelancet.com, hinzugefügt am 05.12.2020

• Efficacy and Safety of Molnupiravir (MK-4482) in Hospitalized Adult Participants With COVID-19 (MK-4482-001)

  clinicaltrials.gov, hinzugefügt am 04.12.2020

• Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine and Pyronaridine: In vitro Activity Against SARS-CoV-2 and Potential Mechanisms

  biorxiv.org, hinzugefügt am 03.12.2020

• A two-arm, randomized, controlled, multi-centric, open-label Phase-2 study to evaluate the efficacy and safety of Itolizumab in moderate to severe ARDS patients due to COVID-19

  medrxiv.org, hinzugefügt am 03.12.2020

• A five day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness

  sciencedirect.com, hinzugefügt am 03.12.2020

• Low-dose ruxolitinib plus steroid in severe SARS-CoV-2 pneumonia

  nature.com, hinzugefügt am 01.12.2020

• Ivermectin: Latin America’s embrace of an unproven COVID treatment is hindering drug trials

  nature.com, hinzugefügt am 29.11.2020

• Ivermectin: Latin America’s embrace of an unproven COVID treatment is hindering drug trials

  nature.com, hinzugefügt am 29.11.2020

• A COVID-19 Prophylaxis? Lower incidence associated with prophylactic administration of Ivermectin

  sciencedirect.com, hinzugefügt am 29.11.2020

• VIP in the Treatment of Critical COVID-19 With Respiratory Failure in Patients With Severe Comorbidity: A Prospective Externally-Controlled Trial

  papers.ssrn.com, hinzugefügt am 28.11.2020

• Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CLpro and PLpro), spike protein, RNA-dependent RNA polymerase (RdRp) and angiotensin-converting enzyme II receptor (ACE2)

  sciencedirect.com, hinzugefügt am 27.11.2020

• Efficacy and Safety of Favipiravir, an Oral RNA-Dependent RNA Polymerase Inhibitor, in Mild-to-Moderate COVID-19: A Randomized, Comparative, Open-Label, Multicenter, Phase 3 Clinical Trial

  sciencedirect.com, hinzugefügt am 27.11.2020

• Leronlimab

  globenewswire.com, hinzugefügt am 27.11.2020

• Colchicine to be investigated as a possible treatment for COVID-19 in the RECOVERY trial

  recoverytrial.net, hinzugefügt am 27.11.2020

• Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?

  meridian.allenpress.com, hinzugefügt am 26.11.2020

• baricitinib/ dexamethasone

  nih.gov, hinzugefügt am 26.11.2020

• (AVIPTADIL) IN PATIENTS WITH CRITICAL COVID-19 AND SEVERE COMORBIDITY: 72% SURVIVAL SEEN IN ICU PATIENTS

  relieftherapeutics.com, hinzugefügt am 24.11.2020

• Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial

  medrxiv.org, hinzugefügt am 24.11.2020

• Nitazoxanide for Repurposing in COVID-19

  sciencedirect.com, hinzugefügt am 22.11.2020

• Tocilizumab effective in treating sickest COVID-19 patients

  recover-europe.eu, hinzugefügt am 20.11.2020

• Roche's Actemra helps the sickest COVID-19 patients

  reuters.com, hinzugefügt am 20.11.2020

• Repurposing Fostamatinib to Combat SARS-CoV-2-Induced Acute Lung Injury

  cell.com, hinzugefügt am 19.11.2020

• Synergistic Effect of Quercetin and Vitamin C Against COVID-19

  papers.ssrn.com, hinzugefügt am 18.11.2020

• Re-recognizing bromhexine hydrochloride: pharmaceutical properties and its possible role in treating pediatric COVID-19

  ncbi.nlm.nih.gov, hinzugefügt am 18.11.2020

• Anakinra in hospitalized patients with severe COVID-19 pneumonia requiring oxygen therapy

  sciencedirect.com, hinzugefügt am 18.11.2020

• Ivermectin and Doxycycline

  iaimjournal.com, hinzugefügt am 17.11.2020

• Interferon-b trial shows positive results

  oxfordbrc.nihr.ac.uk, hinzugefügt am 17.11.2020

• Hinweise, dass eine frühe Therapie mit Interferon-beta-1a-Inhalation oder Fluvoxamin helfen könnte

  aerztezeitung.de, hinzugefügt am 17.11.2020

• liposome-based curcumin: lipocurc to restore and boost brain health in COVID-19 syndrome

  sciencedirect.com, hinzugefügt am 16.11.2020

• Use of Ivermectin in the Prophylaxis and Treatment of COVID-19

  osf.io, hinzugefügt am 15.11.2020

• Efficacy and Safety of Ivermectin for Treatment and prophylaxis

  researchsquare.com, hinzugefügt am 14.11.2020

• NIHR-supported phase 3 trial of nebulised interferon beta

  nihr.ac.uk, hinzugefügt am 14.11.2020

• Antidepressivum Fluvoxamin

  aerzteblatt.de, hinzugefügt am 14.11.2020

• Nebulised interferon beta-1a for patients with COVID-19

  thelancet.com, hinzugefügt am 13.11.2020

• Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001)

  thelancet.com, hinzugefügt am 13.11.2020

• Fluvoxamine vs Placebo and Clinical Deterioration

  jamanetwork.com, hinzugefügt am 13.11.2020

• is there a role for bromhexine as add-on therapy?

  ncbi.nlm.nih.gov, hinzugefügt am 12.11.2020

• COVID-19 Patients Receiving Compassionate Use Leronlimab

  academic.oup.com, hinzugefügt am 12.11.2020

• High-Dose Ivermectin in Adults

  papers.ssrn.com, hinzugefügt am 12.11.2020

• Alkaloide

  sciencedirect.com, hinzugefügt am 10.11.2020

• PPI / Magenschutz

  onlinelibrary.wiley.com, hinzugefügt am 09.11.2020

• Artemisinin-Piperaquine

  sciencedirect.com, hinzugefügt am 08.11.2020

• ACE2 (hrsACE2)

  nature.com, hinzugefügt am 06.11.2020

• Intranasal fusion inhibitory lipopeptide

  biorxiv.org, hinzugefügt am 05.11.2020

• Ivermectin

  trialsitenews.com, hinzugefügt am 05.11.2020

• Interferon

  clinicaltrialsregister.eu, hinzugefügt am 05.11.2020

• synthetic nanobody

  biorxiv.org, hinzugefügt am 05.11.2020

• Aprotinin Inhibits SARS-CoV-2 Replication

  mdpi.com, hinzugefügt am 05.11.2020

• Colchicine

  hindawi.com, hinzugefügt am 01.11.2020

• Azelastin

  biorxiv.org, hinzugefügt am 01.11.2020

• cetirizine - famotidine

  sciencedirect.com, hinzugefügt am 01.11.2020

• Prozac

  tandfonline.com, hinzugefügt am 01.11.2020

• Nicotin

  papers.ssrn.com, hinzugefügt am 01.11.2020

• Prozac

  n-tv.de, hinzugefügt am 01.11.2020

• Candesartan

  sciencedirect.com, hinzugefügt am 01.11.2020

• Statine

  sciencedaily.com, hinzugefügt am 01.11.2020

• EIDD-2801

  researchsquare.com, hinzugefügt am 01.11.2020

• Doxycyclin

  ncbi.nlm.nih.gov, hinzugefügt am 01.11.2020

• Cyclosporin

  sciencedirect.com, hinzugefügt am 01.11.2020

• Favipiravir

  trialsitenews.com, hinzugefügt am 01.11.2020

• Famotidin

  medrxiv.org, hinzugefügt am 01.11.2020

• getestete Medikamente

  frontiersin.org, hinzugefügt am 01.11.2020

Keine Quelle enthält diesen Text.